Triple

T4061238
Position Surface form Disambiguated ID Type / Status
Subject Center for Biologics Evaluation and Research E86214 entity
Predicate hasDivision P35 FINISHED
Object Office of Biostatistics and Pharmacovigilance E392789 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Office of Biostatistics and Pharmacovigilance | Statement: [Center for Biologics Evaluation and Research, hasDivision, Office of Biostatistics and Pharmacovigilance]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Office of Biostatistics and Pharmacovigilance
Context triple: [Center for Biologics Evaluation and Research, hasDivision, Office of Biostatistics and Pharmacovigilance]
  • A. Office of Biostatistics chosen
    The Office of Biostatistics is a specialized FDA unit that provides statistical expertise and evaluation for drug development and regulatory decision-making.
  • B. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • C. Office of Pharmaceutical Quality
    The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
  • D. Department of Biostatistics
    The Department of Biostatistics at the Harvard T.H. Chan School of Public Health is a leading academic center for developing and applying statistical methods to advance biomedical, public health, and quantitative science research.
  • E. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69aed93c69208190a4efac0efe3cd69b completed March 9, 2026, 2:29 p.m.
NER Named-entity recognition batch_69aefbd4acb0819093bcffcd05ed8e6f completed March 9, 2026, 4:56 p.m.
NED1 Entity disambiguation (via context triple) batch_69b562ac25848190951431c9c853cc59 completed March 14, 2026, 1:29 p.m.
Created at: March 9, 2026, 3:38 p.m.